Soluble IL-17RC variant and uses thereof

Details for Australian Patent Application No. 2006328899 (hide)

Owner Laboratoires Serono S.A.

Inventors Magnenat, Laurent; Power, Christine

Agent Griffith Hack

Pub. Number AU-A-2006328899

PCT Pub. Number WO2007/071439

Priority 60/759,449 17.01.06 US; 05112854.4 22.12.05 EP

Filing date 22 December 2006

Wipo publication date 28 June 2007

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/071439 Priority application(s): WO2007/071439

17 July 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 19 Jun 2008

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328900-Inhibitors of CCR9 activity

2006328896-Stent-valves for valve replacement and associated methods and systems for surgery